2024-512532-30-00招募中1 期
Phase Ib Safety, Tolerability and Pharmacokinetic Study of Subcutaneously Administered HER-096 in Healthy Volunteer Subjects and Patients with Parkinson’s Disease
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Head of Clinical Operations
Scientific
Herantis Pharma Oyj
研究点 (2)
Loading locations...
相似试验
终止
1 期
An early phase study of Abraxane combined with Phenelzine Sulfate in patients with metastatic or advanced breast cancerInoperable locally advanced breast cancerCancer - BreastMetastatic breast cancerACTRN12617000943347EpiAxis Therapeutics Pty Ltd8
已完成
1 期
This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357HealthyPsoriasisNCT03279978Boehringer Ingelheim83
进行中（未招募）
1 期
Phase 2 safety and tolerability study using ANX005 for ALSAmyotrophic Lateral Scelrosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-000325-26-FRAnnexon Biosciences25
已完成
1 期
Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel nano-dispersion: A randomized, open label, dose ranging, active controlled, comparative, parallel groups, and multi-centric study.CTRI/2010/091/001122Sun Pharma Advanced Research Company Ltd30
已完成
1 期
A pharmacokinetic, safety, and tolerability study of paclitaxel administered once a week in subjects with advanced solid malignancies in Indian population.CTRI/2011/11/002124Sun Pharma Advanced Research Company Ltd21